BamSEC and AlphaSense Join Forces
Learn More

Jazz Pharmaceuticals plc

NASDAQ: JAZZ    
Share price (10/2/25): $137.21    
Market cap (10/2/25): $8.323 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 8 pages Renee Gala Address on File Re: CEO Employment Agreement Dear Renee, This Letter Agreement (“Agreement”) Memorializes the Terms and Conditions of Your Promotion to the Position of President and Chief Executive Officer (“CEO”) of Jazz Pharmaceuticals. This Agreement Will Be Effective as of August 11, 2025 (The "Effective Date"). 1. Employment Duties and Board Position; Best Efforts; Work Location
12/34/56
EX-10.1B
from 10-Q 71 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because It Is Both (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1A
from 10-Q 79 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because It Is Both (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.4
from 10-Q 32 pages Jazz Pharmaceuticals plc Executive Committee Severance Benefit Plan
12/34/56
EX-10.2
from 10-Q 30 pages Supply Agreement Between Jazz Pharmaceuticals, Inc., 3180 Porter Drive, Palo Alto, Ca 94304 (Hereinafter “JAZZ Pharmaceuticals”) and Siegfried (USA) Inc, 33 Industrial Park Road, Pennsville, Nj, 08070, (Hereinafter "Siegfried") Recitals
12/34/56
EX-10.1
from 8-K 28 pages Certain Information Identified by [*] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential United States District Court Northern District of California San Francisco Division
12/34/56
EX-10.17B
from 10-K 1 page Sign-On Bonus Repayment Agreement
12/34/56
EX-10.1
from 8-K 245 pages Material contract
12/34/56
EX-10.2
from 10-Q 4 pages May 18, 2024 Samantha Pearce Address on File Re: Offer of Promotion to Evp, Chief Commercial Officer Dear Sam,
12/34/56
EX-10.1
from 8-K 230 pages Amendment No. 2
12/34/56
EX-10.2
from 10-Q 4 pages Jazz Pharmaceuticals plc Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 4 pages January 30, 2024 Philip Johnson [Address on File] Re: Offer of Employment With Jazz Pharmaceuticals Dear Philip, as Discussed, I Am Very Pleased to Invite You to Join the Jazz Pharmaceuticals Group. This Letter Sets Out the Terms of Your Employment With JAZZ Pharmaceuticals, Inc. (“JAZZ Pharmaceuticals” or the “Company”)
12/34/56
EX-10.21C
from 10-K 13 pages Jazz Pharmaceuticals plc Amended and Restated 2007 Employee Stock Purchase Plan
12/34/56
EX-10.20A
from 10-K 32 pages Rules of the Gw Pharmaceuticals PLC 2020 Long-Term Incentive Plan
12/34/56
EX-10.18I
from 10-K 24 pages Jazz Pharmaceuticals plc 2011 Equity Incentive Plan
12/34/56
EX-10.17B
from 10-K 1 page Liz Henderson New Hire Equity Award Dear Liz,
12/34/56
EX-10.17A
from 10-K 17 pages Offer of Employment With Jazz Pharmaceuticals Ireland Limited
12/34/56
EX-10.1
from 8-K 234 pages Amendment No. 1
12/34/56
EX-10.3
from 10-Q 3 pages Jazz Pharmaceuticals plc Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 33 pages Jazz Pharmaceuticals plc Amended and Restated Executive Change in Control and Severance Benefit Plan
12/34/56